Combined Type 2 Diabetes and Ischemic Heart Disease: Double Jeopardy

Publisher： Karger

E-ISSN： 1424-0556|1|3|129-131

ISSN： 1422-9528

Source： Heart Drug, Vol.1, Iss.3, 2001-07, pp. : 129-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Optimisation of the Management of Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus

By Wilson S.H.   Kennedy F.P.   Garratt K.N.  

Drugs & Aging, Vol. 18, Iss. 5, 2001-01 ,pp. : 325-333

Adis International

Access to resources Recommend Favorite

Thiazolidinediones may double the risk of heart failure (HF) among patients receiving such drugs for type 2 diabetes mellitus

By  

Reactions Weekly, Vol. 1, Iss. 1162, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes Mellitus

By Britton M.E.   denver A.E.   Mohamed-Ali V.   Yudkin J.S.  

Clinical Drug Investigation, Vol. 16, Iss. 4, 1998-10 ,pp. : 303-317

Adis International

Access to resources Recommend Favorite

Alzheimer's Disease and Type 2 Diabetes: What Is the Connection?

By  

The Consultant Pharmacist, Vol. 30, Iss. 2, 2015-02 ,pp. : 112-115

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

New Insights into the Combined Burden of Type 2 Diabetes and Hypertension

By  

Heart Drug, Vol. 3, Iss. 1, 2003-07 ,pp. : 25-33

Karger

Access to resources Recommend Favorite